Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Nonviral Regenerative Gene Therapy of Mammalian Cutaneous Damages
A. M. Efremov
, I. V. Dukhovlinov
, E. B. Dizhe
, S. V. Burov
, M. V. Leko
, B. N. Akifiev
, D. A. Mogilenko
, I. A. Ivanov
, A. P. Perevozchikov
, S. V. Orlov
Division of Immunobiology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nonviral Regenerative Gene Therapy of Mammalian Cutaneous Damages'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Expression Vector
100%
Cutaneous Injury
100%
Non-viral
100%
Regenerative Gene Therapy
100%
Molecular Conjugates
100%
High Efficiency
50%
Gene Therapy
50%
Therapy Approaches
50%
Cell Proliferation
50%
Growth Factors
50%
Wound Healing
50%
Plasmid DNA (pDNA)
50%
Superficial Tissue
50%
Transferrin Receptor 1 (TfR1)
50%
Free Expression
50%
Delivery Tool
50%
Human Genes
25%
Trauma
25%
Gene Delivery
25%
Fold Increase
25%
Viral Vectors
25%
Ligand-receptor Binding
25%
Insulin-like
25%
Modern Medicine
25%
Non-viral Gene Delivery
25%
Tissue Damage
25%
Peptide Ligand
25%
Tissue Regeneration
25%
Receptor-mediated Endocytosis
25%
Nuclear Localization
25%
Extracellular Matrix Deposition
25%
Popular
25%
Luciferase Activity
25%
Low Toxicity
25%
Synthetic Humans
25%
Targeted Gene Delivery
25%
Luciferase Gene
25%
T Antigen
25%
Wound Area
25%
Damage Area
25%
Wound Burn
25%
Wound Treatment
25%
Polyelectrolytic Complexes
25%
SV40 Virus
25%
Incised Wound
25%
Pharmacology, Toxicology and Pharmaceutical Science
Gene Delivery
100%
Wound
100%
Luciferase
66%
Wound Healing
66%
Plasmid DNA
66%
Transferrin Receptor
66%
Tissue Injury
33%
Growth Factor
33%
Receptor-Mediated Endocytosis
33%
Viral Vector
33%
Simian Virus 40
33%
Burn
33%
Somatomedin C
33%
Absence of Side Effects
33%